Ignite Creation Date:
2025-12-24 @ 1:49 PM
Ignite Modification Date:
2026-01-01 @ 6:41 PM
Study NCT ID:
NCT04512495
Status:
COMPLETED
Last Update Posted:
2021-12-10
First Post:
2020-08-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma?
Sponsor:
Institut Claudius Regaud
Organization:
Study Overview
Official Title:
Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma?
Status:
COMPLETED
Status Verified Date:
2021-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SAMHY SARCOME
Brief Summary:
Pilot, prospective, monocentric study aimed at evaluating the rate of patients with circulating "cancer cell/macrophage" hybrid cells in the peripheral blood.
The study will be conducted on a population of patients with sarcoma and treated in the context of routine care.
For each included patient, blood samples will be collected during baseline visit and after the initiation therapy.
At the end of the 2nd blood collection, the patient will have completed his participation in the study.
The study will be conducted on a population of patients with sarcoma and treated in the context of routine care.
For each included patient, blood samples will be collected during baseline visit and after the initiation therapy.
At the end of the 2nd blood collection, the patient will have completed his participation in the study.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: